A phase II multicenter study of aflibercept (AFL) in combination with cisplatin (C) and pemetrexed (P) in patients with previously untreated advanced/metastatic nonsquamous non-small cell lung cancer (NSCLC).
暂无分享,去创建一个
J. Neal | H. Wakelee | J. Rigas | A. Adjei | N. Leighl | Liming Liu | J. Brahmer | M. Modiano | R. Jotte | Hongbin Chen | J. Lisano